Phase 2 Idiopathic Hypersomnia Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited248 enrolled37 locationsNCT06752668
Recruiting
Phase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Centessa Pharmaceuticals (UK) Limited90 enrolled24 locationsNCT07096674
Recruiting
Phase 2
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Takeda96 enrolled29 locationsNCT06812078
Recruiting
Phase 2Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Idiopathic HypersomniaNarcolepsy Type 1Narcolepsy Type 2
Alkermes, Inc.256 enrolled46 locationsNCT06767683
Recruiting
Phase 2
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia
Idiopathic Hypersomnia
Alkermes, Inc.96 enrolled48 locationsNCT06843590
Recruiting
Phase 2
a Chronobiological Treatment Combining Evening Melatonin and Morning Light Therapy in Idiopathic Hypersomnia: a Prospective, Double Bind, Randomized, Placebo-controlled -Trial
Idiopathic Hypersomnia
University Hospital, Strasbourg, France72 enrolled1 locationNCT06252571
Not Yet Recruiting
Phase 2
Efficacy, Safety, and Tolerability of BRP-185 (Bupropion immediate-release (IR) and sustained-release (SR)) in Adults with Idiopathic Hypersomnia
Idiopathic Hypersomnia
Bioron Pharma120 enrolled1 locationACTRN12625000555459